← Teladoc Health, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $50.0m | $42.8m | $424.0m | $514.4m | $733.3m | $893.5m | $918.2m | $1.1b | $1.3b | $781.1m | |
| Prepaid Expense and Other Assets, Current | $3.1m | $6.8m | $10.6m | $14.0m | $47.3m | $87.4m | $130.3m | $118.4m | $113.3m | $107.0m | |
| Inventory, Net | — | — | — | $0 | $56.5m | $73.1m | $56.3m | $29.5m | $38.1m | $38.2m | |
| Assets, Current | $82.7m | $156.2m | $532.7m | $588.0m | $1.1b | $1.2b | $1.3b | $1.5b | $1.7b | $1.1b | |
| Property, Plant and Equipment, Net | $7.5m | $9.0m | $10.1m | $10.3m | $28.6m | $27.2m | $29.6m | $32.0m | $29.5m | $27.0m | |
| Goodwill | $188.2m | $498.5m | $737.2m | $746.1m | $14.6b | $14.5b | $1.1b | $1.1b | $283.2m | $283.2m | |
| Intangible Assets, Net (Excluding Goodwill) | $24.9m | $159.8m | $247.4m | $225.5m | $2.0b | $1.9b | $1.8b | $1.7b | $1.4b | $1.3b | |
| Operating Lease, Right-of-Use Asset | — | — | — | $26.5m | $46.6m | $46.8m | $41.8m | $40.1m | $27.1m | $26.1m | |
| Other Assets, Noncurrent | $415k | $858k | $1.4m | $6.5m | $18.4m | $20.7m | $48.5m | $80.3m | $81.5m | $105.8m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $13.8m | $27.1m | $43.6m | $56.9m | $169.3m | $169.0m | $210.6m | $217.4m | $214.1m | $192.8m | |
| Assets | $303.7m | $824.4m | $1.5b | $1.6b | $17.8b | $17.7b | $4.3b | $4.4b | $3.5b | $2.9b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | $0 | $5.1m | $11.4m | $12.7m | $13.6m | $10.8m | $10.3m | $11.0m | |
| Accounts Payable, Current | $2.2m | $3.9m | $7.8m | $9.1m | $46.0m | $47.3m | $47.7m | $43.6m | $33.1m | $48.0m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $25.0m | $43.1m | $41.8m | $38.0m | $42.8m | $32.1m | $34.2m | |
| Deferred Revenue, Current | $1.0m | $4.1m | — | $2.3m | $52.4m | $75.6m | $90.5m | $95.7m | $79.3m | $62.3m | |
| Deferred Revenue, Noncurrent | — | — | — | — | $2.4m | $3.8m | $3.9m | $95.7m | $79.3m | $62.3m | |
| Long-term Debt, Excluding Current Maturities | $42.4m | — | — | — | — | — | — | — | — | — | |
| Long-term Debt, Current Maturities | $2.0m | — | — | — | $42.6m | $0 | — | — | — | — | |
| Liabilities, Current | $21.1m | $40.3m | $62.4m | $90.2m | $332.6m | $331.0m | $399.8m | $420.6m | $941.5m | $404.7m | |
| Deferred Income Tax Liabilities, Net | $1.7m | $12.9m | $32.4m | $21.7m | $102.1m | $75.8m | $50.9m | $49.5m | $49.9m | $28.9m | |
| Other Liabilities, Noncurrent | $7.6m | $4.9m | $6.2m | $11.5m | $1.6m | $1.5m | $1.6m | $1.1m | $720k | $643k | |
| Deferred Tax Liabilities, Net | $1.7m | $12.9m | $32.4m | $21.7m | $102.1m | $75.8m | $50.9m | $49.5m | $49.9m | $28.9m | |
| Liabilities | — | — | — | — | — | — | — | — | $2.0b | $1.5b | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $46k | $61k | $70k | $73k | $150k | $160k | $163k | $167k | $173k | $178k | |
| Retained Earnings (Accumulated Deficit) | ($204.7m) | ($311.6m) | ($408.7m) | ($507.5m) | ($992.7m) | ($1.4b) | ($15.0b) | ($15.2b) | ($16.2b) | ($16.4b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($1k) | $4.1m | ($13.1m) | ($17.2m) | $18.5m | ($6.3m) | ($42.8m) | ($37.0m) | ($38.4m) | ($34.7m) | |
| Additional Paid in Capital, Common Stock | $435.6m | $866.3m | $1.4b | $1.5b | $16.9b | $17.5b | $17.4b | $17.6b | $17.8b | $17.9b | |
| Stockholders' Equity Attributable to Parent | $230.9m | $558.9m | $1.0b | $1.0b | $15.9b | $16.0b | $2.3b | $2.3b | $1.5b | $1.4b | |
| Liabilities and Equity | $303.7m | $824.4m | $1.5b | $1.6b | $17.8b | $17.7b | $4.3b | $4.4b | $3.5b | $2.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.